Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous LeukemiaWeiguo Zhang, Michael Andreeff|JNCI Journal of the National Cancer Institute|2008Cited by 338
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in <i>FLT3</i>-mutated acute myeloid leukemias: from concept to clinical trialWeiguo Zhang, Michael Andreeff|Haematologica|2018Cited by 49